The amount of amyloid ² (A²) in the brains of people with mild cognitive impairment (MCI) is contributing to early memory loss, and increases with severity of symptoms, finds a new study. The non-invasive study which used 18F-florbetaben to find A² plaques in brain scans to also show that in MCI the affect of A² on memory loss is independent of other aspects of mental decline.